Acquired Factor XIII Deficiency Is Common during ECMO Therapy and Associated with Major Bleeding Events and Transfusion Requirements.
Matthias NoitzRoxane BrooksJohannes SzaszDennis JennerCarl BöckNiklas KrennerMartin W DünserJens MeierPublished in: Journal of clinical medicine (2023)
In this retrospective single centre study, acquired factor XIII deficiency was observed in 69% of adult ECMO patients with a high bleeding risk. Factor XIII deficiency was associated with higher rates of major bleeding events and transfusion requirements.